Please subscribe to receive our research, articles and invitations as soon as they are available. Our research is classified as a ‘minor non-monetary benefit’ as defined by the Markets in Financial Instruments Directive II.

Basilea Pharmaceutica

21 December 2020

Derazantinib

19 October 2020 

Initiation of coverage

Calvine Partners LLP, Registered in Scotland, Partnership No. SO306987

Registered address: 23 Melville Street, Edinburgh, EH3 7PE

Privacy Policy

Linkedin%20icon_edited.png